Compagnie Lombard Odier SCmA Boosts Stake in Intuitive Surgical, Inc. $ISRG

Compagnie Lombard Odier SCmA lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,721 shares of the medical equipment provider’s stock after purchasing an additional 4,410 shares during the period. Compagnie Lombard Odier SCmA’s holdings in Intuitive Surgical were worth $16,870,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of ISRG. Rossmore Private Capital increased its holdings in Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after acquiring an additional 20 shares in the last quarter. Activest Wealth Management increased its stake in shares of Intuitive Surgical by 21.7% during the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 20 shares in the last quarter. Vertex Planning Partners LLC raised its position in shares of Intuitive Surgical by 2.3% during the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after purchasing an additional 21 shares during the last quarter. Accredited Investors Inc. raised its position in shares of Intuitive Surgical by 2.0% during the 3rd quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock worth $474,000 after purchasing an additional 21 shares during the last quarter. Finally, SPC Financial Inc. lifted its stake in Intuitive Surgical by 1.3% in the 3rd quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider’s stock valued at $722,000 after buying an additional 21 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares in the company, valued at approximately $1,772,480. The trade was a 81.80% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 70,011 shares of company stock worth $38,858,275. 0.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on ISRG shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday. Raymond James Financial raised their price objective on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Citigroup reaffirmed a “neutral” rating and set a $590.00 target price (down previously from $635.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. Finally, TD Cowen upgraded shares of Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Trading Up 1.0%

NASDAQ ISRG opened at $492.84 on Tuesday. The stock has a fifty day simple moving average of $548.13 and a 200-day simple moving average of $510.63. The stock has a market cap of $175.02 billion, a PE ratio of 62.46, a P/E/G ratio of 3.79 and a beta of 1.65. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.21 earnings per share. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.